Michel Ducreux
Michel Ducreux
Université Paris-Saclay, Gustave Roussy
Adresse e-mail validée de
Citée par
Citée par
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
T Conroy, F Desseigne, M Ychou, O Bouché, R Guimbaud, Y Bécouarn, ...
New England journal of medicine 364 (19), 1817-1825, 2011
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lievre, JB Bachet, D Le Corre, V Boige, B Landi, JF Emile, JF Côté, ...
Cancer research 66 (8), 3992-3995, 2006
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
RS Finn, S Qin, M Ikeda, PR Galle, M Ducreux, TY Kim, M Kudo, V Breder, ...
New England Journal of Medicine 382 (20), 1894-1905, 2020
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo …
CS Fuchs, J Tomasek, CJ Yong, F Dumitru, R Passalacqua, C Goswami, ...
The Lancet 383 (9911), 31-39, 2014
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
JP Gérard, T Conroy, F Bonnetain, O Bouché, O Chapet, ...
Journal of clinical oncology 24 (28), 4620-4625, 2006
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
A Lievre, JB Bachet, V Boige, A Cayre, D Le Corre, E Buc, M Ychou, ...
Journal of clinical oncology 26 (3), 374-379, 2008
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial
C Louvet, R Labianca, P Hammel, G Lledo, MG Zampino, T André, ...
Journal of Clinical Oncology 23 (15), 3509-3516, 2005
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Ducreux, AS Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, ...
Annals of Oncology 26, v56-v68, 2015
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ...
Oncogene 29 (4), 482-491, 2010
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
P Laurent-Puig, A Cayre, G Manceau, E Buc, JB Bachet, T Lecomte, ...
Journal of clinical oncology 27 (35), 5924-5930, 2009
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus …
U Vanhoefer, P Rougier, H Wilke, MP Ducreux, AJ Lacave, E Van Cutsem, ...
Journal of Clinical Oncology 18 (14), 2648-2657, 2000
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure
R Adam, DA Wicherts, RJ de Haas, O Ciacio, F Lévi, B Paule, M Ducreux, ...
J Clin Oncol 27 (11), 1829-1835, 2009
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
E Mitry, E Baudin, M Ducreux, JC Sabourin, P Rufie, T Aparicio, P Lasser, ...
British Journal of Cancer 81 (8), 1351-1355, 1999
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy
D Elias, F Blot, A El Otmany, S Antoun, P Lasser, V Boige, P Rougier, ...
Cancer 92 (1), 71-76, 2001
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year
T de Baere, D Elias, C Dromain, MGE Din, V Kuoch, M Ducreux, V Boige, ...
American Journal of Roentgenology 175 (6), 1619-1625, 2000
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial
G Pelletier, M Ducreux, F Gay, M Luboinski, H Hagège, D Thong, ...
Journal of hepatology 29 (1), 129-134, 1998
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging
C Dromain, T de Baere, J Lumbroso, H Caillet, A Laplanche, V Boige, ...
Journal of clinical oncology 23 (1), 70-78, 2005
During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma
D Elias, T De Baere, A Roche, M Ducreux, J Leclere, P Lasser
British Journal of Surgery 86 (6), 784-788, 1999
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
D Elias, M Bonnay, JM Puizillou, S Antoun, S Demirdjian, A El Otmany, ...
Annals of oncology 13 (2), 267-272, 2002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20